145 related articles for article (PubMed ID: 36567345)
1. Assessment of regulatory T cells (Tregs) and Foxp3 methylation level in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy.
Sabir SF; Matti BF; Alwatar WMA
Immunogenetics; 2023 Apr; 75(2):145-153. PubMed ID: 36567345
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of regulatory T cells in newly diagnosed chronic myeloid leukemia patients.
Zahran AM; Badrawy H; Ibrahim A
Int J Clin Oncol; 2014 Aug; 19(4):753-60. PubMed ID: 24068564
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of monocyte-derived dendritic cells, T regulatory and Th17 cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.
Hus I; Tabarkiewicz J; Lewandowska M; Wasiak M; Wdowiak P; Kusz M; Legieć M; Dmoszyńska A; Roliński J
Folia Histochem Cytobiol; 2011; 49(1):153-60. PubMed ID: 21526503
[TBL] [Abstract][Full Text] [Related]
4. Elevated Methylation of FOXP3 (Forkhead Box P3)-TSDR (Regulatory T-Cell-Specific Demethylated Region) Is Associated With Increased Risk for Adverse Outcomes in Patients With Acute Coronary Syndrome.
Zhu L; Jia L; Liu Z; Zhang Y; Wang J; Yuan Z; Hui R
Hypertension; 2019 Sep; 74(3):581-589. PubMed ID: 31327269
[TBL] [Abstract][Full Text] [Related]
5. [Treg Cells,
Wang SL; Dong QF; Li F; Wang J; Sang YQ; Zhang L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):666-670. PubMed ID: 37356924
[TBL] [Abstract][Full Text] [Related]
6. CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors.
Hughes A; Clarson J; Tang C; Vidovic L; White DL; Hughes TP; Yong AS
Blood; 2017 Mar; 129(9):1166-1176. PubMed ID: 28049640
[TBL] [Abstract][Full Text] [Related]
7. Foxp3 TSDR Hypermethylation Is Correlated with Decreased Tregs in Patients with Unexplained Recurrent Spontaneous Abortion.
Zhu L; Liu M; Zhang S; Ou Y; Chen Y; Wei J; Su F; Chen H; Zhang J
Reprod Sci; 2021 Feb; 28(2):470-478. PubMed ID: 32839941
[TBL] [Abstract][Full Text] [Related]
8. Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells.
Polansky JK; Schreiber L; Thelemann C; Ludwig L; Krüger M; Baumgrass R; Cording S; Floess S; Hamann A; Huehn J
J Mol Med (Berl); 2010 Oct; 88(10):1029-40. PubMed ID: 20574810
[TBL] [Abstract][Full Text] [Related]
9. Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy.
Ferri C; Bianchini M; Bengió R; Larripa I
Blood Cells Mol Dis; 2014; 52(2-3):121-5. PubMed ID: 24091144
[TBL] [Abstract][Full Text] [Related]
10. Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia.
Shimazu Y; Shimazu Y; Hishizawa M; Hamaguchi M; Nagai Y; Sugino N; Fujii S; Kawahara M; Kadowaki N; Nishikawa H; Sakaguchi S; Takaori-Kondo A
Cancer Immunol Res; 2016 Feb; 4(2):136-45. PubMed ID: 26681759
[TBL] [Abstract][Full Text] [Related]
11. FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome.
Lü CX; Xu RD; Cao M; Wang G; Yan FQ; Shang SS; Wu XF; Ruan L; Quan XQ; Zhang CT
Atherosclerosis; 2013 Jul; 229(1):263-70. PubMed ID: 23735638
[TBL] [Abstract][Full Text] [Related]
12. Central Role of CD45RA- Foxp3hi Memory Regulatory T Cells in Clinical Kidney Transplantation Tolerance.
Braza F; Dugast E; Panov I; Paul C; Vogt K; Pallier A; Chesneau M; Baron D; Guerif P; Lei H; Laplaud DA; Volk HD; Degauque N; Giral M; Soulillou JP; Sawitzki B; Brouard S
J Am Soc Nephrol; 2015 Aug; 26(8):1795-805. PubMed ID: 25556168
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic immune monitoring of CD4
Lu Z; Xu N; Zhou X; Gao G; Li L; Huang J; Li Y; Lu Q; He B; Pan C; Liu X
Oncol Lett; 2017 Aug; 14(2):1363-1372. PubMed ID: 28808483
[TBL] [Abstract][Full Text] [Related]
14. Aberrant DNA methylation at HOXA4 and HOXA5 genes are associated with resistance to imatinib mesylate among chronic myeloid leukemia patients.
Elias MH; Azlan H; Sulong S; Baba AA; Ankathil R
Cancer Rep (Hoboken); 2018 Aug; 1(2):e1111. PubMed ID: 32721103
[TBL] [Abstract][Full Text] [Related]
15. T regulatory cells in cord blood--FOXP3 demethylation as reliable quantitative marker.
Liu J; Lluis A; Illi S; Layland L; Olek S; von Mutius E; Schaub B
PLoS One; 2010 Oct; 5(10):e13267. PubMed ID: 20967272
[TBL] [Abstract][Full Text] [Related]
16. Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity.
Ferreira RC; Simons HZ; Thompson WS; Rainbow DB; Yang X; Cutler AJ; Oliveira J; Castro Dopico X; Smyth DJ; Savinykh N; Mashar M; Vyse TJ; Dunger DB; Baxendale H; Chandra A; Wallace C; Todd JA; Wicker LS; Pekalski ML
J Autoimmun; 2017 Nov; 84():75-86. PubMed ID: 28747257
[TBL] [Abstract][Full Text] [Related]
17. Disabled C3ar1/C5ar1 Signaling in Foxp3+ T Regulatory Cells Leads to TSDR Demethylation and Long-Term Stability.
Medof ME; Rieder SA; Shevach EM
J Immunol; 2023 Nov; 211(9):1359-1366. PubMed ID: 37756526
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional suppression of Tregs.
Anderson MR; Enose-Akahata Y; Massoud R; Ngouth N; Tanaka Y; Oh U; Jacobson S
J Neuroimmune Pharmacol; 2014 Sep; 9(4):522-32. PubMed ID: 24845974
[TBL] [Abstract][Full Text] [Related]
19. BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian chronic myeloid leukemia patients-Frequency and clinical outcome.
Elias MH; Baba AA; Azlan H; Rosline H; Sim GA; Padmini M; Fadilah SA; Ankathil R
Leuk Res; 2014 Apr; 38(4):454-9. PubMed ID: 24456693
[TBL] [Abstract][Full Text] [Related]
20. FAM167A is a key molecule to induce BCR-ABL-independent TKI resistance in CML via noncanonical NF-κB signaling activation.
Yang T; Sim KY; Ko GH; Ahn JS; Kim HJ; Park SG
J Exp Clin Cancer Res; 2022 Mar; 41(1):82. PubMed ID: 35241148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
